Track topics on Twitter Track topics that are important to you
What is HemoBioTech, Inc.’s current product offering? HemoBioTech, Inc.’s product is HemoTech™, potentially the first viable human blood substitute addressing the broad blood use market. What is HemoBioTech, Inc.’s mission? Our mission is to commercialize HemoTech™ as potentially the first viable substitute for human blood addressing a blood market of over $25 billion. Our goal is to address an increasing demand for a safe and inexpensive human blood substitute product in the United States and around the world through our licensed technology.
5001 Spring Valley Road
Suite 1040- West
United States of America
Phone: (972) 455-8950
What is HemoBioTech, Inc.’s current product offering? HemoBioTech, Inc.’s product is HemoTech™, potentially the first viable human blood substitute addressing the broad blood use market. What ...
We have published hundreds of Hemobiotech news stories on BioPortfolio along with dozens of Hemobiotech Clinical Trials and PubMed Articles about Hemobiotech for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hemobiotech Companies in our database. You can also find out about relevant Hemobiotech Drugs and Medications on this site too.